edaravone has been researched along with Urinary Bladder Neoplasms in 1 studies
Urinary Bladder Neoplasms: Tumors or cancer of the URINARY BLADDER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We investigated the changes in reactive oxygen species (ROS) and angiogenesis through angiotensin II (Ang II) type 1 receptor (AT1R) after the development of acquired platinum resistance in bladder cancer." | 7.77 | Acquired platinum resistance enhances tumour angiogenesis through angiotensin II type 1 receptor in bladder cancer. ( Kikuchi, E; Kosaka, T; Miyajima, A; Miyazaki, Y; Oya, M; Shirakawa, H; Shirotake, S; Tanaka, N, 2011) |
| "We investigated the changes in reactive oxygen species (ROS) and angiogenesis through angiotensin II (Ang II) type 1 receptor (AT1R) after the development of acquired platinum resistance in bladder cancer." | 3.77 | Acquired platinum resistance enhances tumour angiogenesis through angiotensin II type 1 receptor in bladder cancer. ( Kikuchi, E; Kosaka, T; Miyajima, A; Miyazaki, Y; Oya, M; Shirakawa, H; Shirotake, S; Tanaka, N, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tanaka, N | 1 |
| Miyajima, A | 1 |
| Kosaka, T | 1 |
| Miyazaki, Y | 1 |
| Shirotake, S | 1 |
| Shirakawa, H | 1 |
| Kikuchi, E | 1 |
| Oya, M | 1 |
1 other study available for edaravone and Urinary Bladder Neoplasms
| Article | Year |
|---|---|
Acquired platinum resistance enhances tumour angiogenesis through angiotensin II type 1 receptor in bladder cancer.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antipyrine; Cell Line, Tumor; Cisp | 2011 |